Jong S. Rim
Pennington Biomedical Research Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jong S. Rim.
Cellular Reprogramming | 2013
Jaroslaw Staszkiewicz; Rachel A. Power; Lettie L. Harkins; Christian W. Barnes; Karen L. Strickler; Jong S. Rim; Kenneth R. Bondioli; Kenneth J. Eilersten
Histone deacetylases (HDACs) catalyze deacetylation of histones that results in altered transcriptional activity. Inhibitors of HDACs have been shown to induce transcriptional changes that contribute positively to reprogramming somatic cells either by nuclear transfer or inducing a pluripotent state. However, the exact molecular mechanisms whereby HDAC inhibitors function and the specificity of the HDAC isoforms in cell reprogramming are not yet fully understood. Herein, we report the ability of individual isoform-specific HDACs to modulate endogenous expression of pluripotency-associated genes in bovine somatic cells. This in vitro study showed that a transient selective depletion of HDACs resulted in elevated mRNA levels of Oct-4, Sox2, and Nanog. In particular, we found that inhibition of specific HDAC isoforms using small interfering (si) RNA significantly increased expression of Nanog, a key factor required for totipotency induced by somatic cell nuclear transfer and for maintaining pluripotency in embryonic and induced pluripotent stem cells. Our study suggests that this gene might be the most susceptible to HDAC activity inhibition. Moreover, a regulatory role of the class III HDAC, SIRT3, on an Oct4-Sox2-Nanog transcriptional network was revealed. We observed the upregulation of pluripotency-related genes by depletion of SIRT3. SIRT3 is localized to mitochondria and is associated with energy metabolism processes, suggesting metabolic changes may be linked to reprogramming in bovine fibroblasts. In conclusion, we show that targeting selective HDACs can potentially be useful to enhance reprogramming and that sirtuins may play a pivotal role in somatic cell reprogramming by upregulating an Oct4-Sox2-Nanog transcriptional network. Dedifferentiating donor somatic cells by upregulating developmentally important genes through specific knockdown of epigenetic targets, in particular HDACs, may provide a path to improving livestock cloning and the in vitro production of pluripotent cells.
Methods of Molecular Biology | 2011
Jong S. Rim; Karen L. Strickler; Christian W. Barnes; Lettie L. Harkins; Jaroslaw Staszkiewicz; Rachel A. Power; Kenneth J. Eilertsen
Small molecules will need to be identified and/or developed that target protein classes limiting reprogramming efficiency. A specific class of proteins includes epigenetic regulators that silence, or minimize expression, of pluripotency genes in differentiated cells. To better understand the role of specific epigenetic modulators in reprogramming, we have used shRNA delivered by lentivirus to assess the significance of individual epi-proteins in reprogramming pluripotent gene expression.
Diabetes | 2003
Martin Rossmeisl; Jong S. Rim; Robert A. Koza; Leslie P. Kozak
Journal of Biological Chemistry | 2002
Jong S. Rim; Leslie P. Kozak
Archive | 2009
Kenneth J. Eilertsen; Rachel A. Power; Jong S. Rim
Archive | 2009
Kenneth J. Eilertsen; Rachel A. Power; Jong S. Rim
Archive | 2002
Leslie P. Kozak; Jong S. Rim
Stem Cell Discovery | 2012
Jong S. Rim; Karen L. Strickler; Christian W. Barnes; Lettie L. Harkins; Jaroslaw Staszkiewicz; Jeffrey M. Gimble; Gregory H. Leno; Kenneth J. Eilertsen
Archive | 2010
Kenneth J. Eilertsen; Jong S. Rim; Rachel A. Power; Jaroslaw Staszkiewicz
Archive | 2012
Kenneth J. Eilertsen; Jong S. Rim; Jaroslaw Staszkiewicz